Three-year results from a clinical trial assessing a new contact lens therapy using a dual-focus 1-day soft contact lens has reportedly been found to help slow myopia progression in children by 59 percent.
The three-year study — whose results were recently presented by CooperVision at the British Contact Lens Association Clinical Conference in Liverpool, England — reportedly assessed a specially-designed, dual-focus myopia control 1-day soft contact lens, called MiSight® dual-focus 1-day lens, in reducing the rate of progression of juvenile-onset myopia. The study reportedly enrolled 144 myopic children aged 8-12 years from Singapore, Canada, England, and Portugal.
The findings reportedly found the dual-focus contact lens — which has alternating visual correction and treatment zones — was effective in slowing myopia progression, with 59 percent as measured by mean cycloplegic spherical equivalent (SE) and 52 percent as measured by mean axial elongation of the eye, when compared to the children in the control group wearing a single vision 1-day contact lens.
Click here to read the full press release.
Like what you read? Follow OptometryWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.